Jackson Laboratory is located in Bar Harbor, ME. The organization was established in 1950. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, Jackson Laboratory employed 2,983 individuals. This organization is the central organization for a national or regional group of organizations. Jackson Laboratory is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, Jackson Laboratory generated $527.5m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 9.6% each year. All expenses for the organization totaled $463.6m during the year ending 12/2020. While expenses have increased by 8.7% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Jackson Laboratory has awarded 33 individual grants totaling $3,519,997. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
THE PURPOSES OF THE LABORATORY ARE SCIENTIFIC, MEDICAL, CHARITABLE, AND EDUCATIONAL. OUR MISSION IS TO DISCOVER PRECISE GENOMIC SOLUTIONS FOR DISEASE AND EMPOWER THE BIOMEDICAL COMMUNITY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DEVELOP AND PROVIDE GENETIC RESOURCESTHE JACKSON LABORATORY (JAX) IS A GLOBAL RESOURCE FOR DEVELOPING, DISTRIBUTING AND ANALYZING INNOVATIVE MODELS OF HUMAN DISEASE. IT OFFERS AN ARRAY OF MODEL CREATION, HUSBANDRY AND DIAGNOSTIC AND ANALYTICAL SERVICES, RANGING FROM CUSTOM BREEDING AND STRAIN PRESERVATION TO DRUG EFFICACY STUDIES AND GENOME SEQUENCING, ALL FOCUSED ON EMPOWERING BASIC SCIENTIFIC RESEARCH AND DRUG DISCOVERY.JAX MAINTAINS CLOSE TO 13,000 GENETICALLY DISTINCT STRAINS OF RESEARCH MICE. IN 2021, DISTRIBUTED THEM TO RESEARCHERS FROM MORE THAN 2,000 ORGANIZATIONS, IN UPWARDS OF 64 COUNTRIES USED JAX RESEARCH MICE TO SUPPORT EFFORTS TO FIND CURES FOR THE WORLD'S MOST DEVASTATING HUMAN DISEASES AND BRING ADVANCED THERAPIES TO PATIENTS. THE LABORATORY ALSO HOSTS THE MOUSE GENOME INFORMATICS DATABASES, THE WORLD'S SOURCE FOR INFORMATION ON MOUSE GENETICS AND BIOLOGY.IN 2021, 600 MOUSE STRAINS WERE DONATED TO THE LABORATORY OR DEVELOPED BY JAX RESEARCH STAFF WITH ACADEMIC/FOUNDATION OR PUBLICLY FUNDED RESEARCH PROGRAMS. THE LABORATORY MAKES THESE RESOURCES PUBLICLY ACCESSIBLE THROUGH ITS REPOSITORY, PRODUCTION AND RESEARCH SERVICES. DISTRIBUTION OF THESE STRAINS HELPS SUPPORT CURES FOR THE WORLD'S MOST PREVALENT HUMAN DISEASES AND ACCELERATES THE TIME TO BRING NEW THERAPIES TO PATIENTS. THE LABORATORY COLLABORATED WITH OTHER NON-PROFIT PATIENT FOUNDATIONS FOR RARE DISEASES TO ESTABLISH MOUSE RESOURCES TO FURTHER PRECLINICAL THERAPEUTIC STUDIES.THE LABORATORY MAKES THE JAX CLINICAL KNOWLEDGEBASE (CKB) RESOURCE PUBLICLY AVAILABLE, ENABLING CLINICIANS, AND TRANSLATIONAL RESEARCHERS TO INTERPRET COMPLEX CANCER GENOMIC PROFILES. ACCEPTANCE AND USAGE OF CKB HAS BEEN STEADILY INCREASING; CKB HAS RECEIVED OVER 750,000 VISITS SINCE ITS LAUNCH IN 2016. THE PUBLIC SITE HAD OVER 2,500,000 PAGE VIEWS IN THAT PERIOD.
BIOMEDICAL RESEARCHTHE LABORATORY'S RESEARCHERS COMBINE EXPERIENCE IN MAMMALIAN GENETICS AND HUMAN GENOMICS TO SHAPE AN INTEGRATED APPROACH TO PERSONALIZED MEDICINE. SCIENTISTS WORK COLLABORATIVELY AND CROSS-DISCIPLINE, LEVERAGING EXPERTISE IN CANCER, IMMUNOLOGY, NEUROGENETICS, LIFE-CYCLE BIOLOGY, THE MICROBIOME, AND COMPUTATIONAL BIOLOGY.MORE THAN 400 JAX STAFF MEMBERS HOLD ADVANCED DEGREES AND THE LABORATORY SUPPORTS MORE THAN 65 RESEARCH TEAMS. FACULTY MEMBERS HAVE 324 ACTIVE SPONSORED RESEARCH COLLABORATION AGREEMENTS WITH 245 ACADEMIC RESEARCH AND CLINICAL INSTITUTIONS. MULTIPLE LABORATORY CENTERS COORDINATE EXPERTISE AROUND CRITICAL RESEARCH AREAS. SINCE 1983 THE LABORATORY HAS HAD A NATIONAL CANCER INSTITUTE-DESIGNATED CANCER CENTER, ONE OF ONLY SEVEN SUCH DESIGNATED INSTITUTIONS IN THE UNITED STATES. TO DATE 26 NOBEL PRIZES ARE ASSOCIATED WITH LABORATORY RESEARCH, EDUCATION PROGRAMS AND RESOURCES.
EDUCATION AND TRAININGTHE LABORATORY OFFERS EDUCATIONAL PROGRAMS FOR SCIENTISTS THROUGHOUT THEIR CAREERS FROM STEM EDUCATION FOR HIGH SCHOOL STUDENTS AND TRAINING FOR SCIENCE AND MATH TEACHERS TO COURSES AND CONFERENCES FOR EXPERIENCED RESEARCHERS DEFINING THE CUTTING EDGE OF GENOMICS INTO THEIR PRACTICES.FOR MORE INFORMATION ON THE LABORATORY'S PROGRAM SERVICES, PLEASE REFER TO THE JACKSON LABORATORY 2021 ANNUAL REPORT AT HTTPS://WWW.JAX.ORG/ABOUT-US/LEGAL-INFORMATION/FINANCIALS
INTERCOMPANY REVENUE/OTHER REVENUE
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Edison T Liu MD Until 1121 President & CEO | OfficerTrustee | 40 | $1,488,347 |
Aurobindo Nair Executive VP & President Jmcrs | Officer | 40 | $1,479,984 |
S Catherine Longley Executive Vice President & COO | Officer | 40 | $866,847 |
Kenneth H Fasman Senior Vice President Research | Officer | 40 | $593,048 |
Charles Miller Ceo, The Jackson Laboratory Anitech Biotech Ltd | 40 | $548,909 | |
Nadia A Rosenthal Scientific Director | Officer | 40 | $515,344 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Ropes & Gray Legal Services | 12/30/21 | $3,603,570 |
Wright-ryan Construction Inc Construction Mgmt | 12/30/21 | $3,030,297 |
Whiting Turner Contracting Construction Mgmt | 12/30/21 | $3,125,175 |
Biotrans Llc Transportation | 12/30/21 | $8,725,873 |
E L Shea Construction Mgmt | 12/30/21 | $3,366,411 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $107,910,459 |
All other contributions, gifts, grants, and similar amounts not included above | $15,001,752 |
Noncash contributions included in lines 1a–1f | $190,199 |
Total Revenue from Contributions, Gifts, Grants & Similar | $122,912,211 |
Total Program Service Revenue | $362,474,943 |
Investment income | $10,458,224 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $28,790 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $31,508,630 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $527,504,036 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $294,660 |
Grants and other assistance to domestic individuals. | $2,045,374 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $6,009,839 |
Compensation of current officers, directors, key employees. | $3,833,788 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $177,564,239 |
Pension plan accruals and contributions | $15,865,068 |
Other employee benefits | $32,609,882 |
Payroll taxes | $13,009,277 |
Fees for services: Management | $0 |
Fees for services: Legal | $6,456,350 |
Fees for services: Accounting | $315,680 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $356,863 |
Fees for services: Other | $14,991,518 |
Advertising and promotion | $1,321,659 |
Office expenses | $1,612,004 |
Information technology | $12,874,549 |
Royalties | $1,092,716 |
Occupancy | $15,963,926 |
Travel | $1,033,331 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | -$25,961 |
Interest | $6,305,113 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $47,661,064 |
Insurance | $2,699,580 |
All other expenses | -$163,405 |
Total functional expenses | $463,558,933 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $174,228,236 |
Pledges and grants receivable | $14,082,968 |
Accounts receivable, net | $53,708,726 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $10,457,156 |
Prepaid expenses and deferred charges | $6,003,604 |
Net Land, buildings, and equipment | $544,778,988 |
Investments—publicly traded securities | $324,775,421 |
Investments—other securities | $62,181,099 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $21,551,430 |
Total assets | $1,211,767,628 |
Accounts payable and accrued expenses | $78,999,564 |
Grants payable | $0 |
Deferred revenue | $7,477,565 |
Tax-exempt bond liabilities | $199,717,633 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $7,054,248 |
Total liabilities | $293,249,010 |
Net assets without donor restrictions | $839,169,016 |
Net assets with donor restrictions | $79,349,602 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $1,211,767,628 |
Over the last fiscal year, Jackson Laboratory has awarded $221,787 in support to 7 organizations.
Grant Recipient | Amount |
---|---|
TOWN OF BAR HARBOR PURPOSE: GENERAL SUPPORT | $112,409 |
CITY OF ELLSWORTH PURPOSE: GENERAL SUPPORT | $53,045 |
Hartford, CT PURPOSE: GENERAL SUPPORT | $23,333 |
Bangor, ME PURPOSE: GENERAL SUPPORT | $10,500 |
Sacramento, CA PURPOSE: GENERAL SUPPORT | $7,500 |
Bar Harbor, ME PURPOSE: GENERAL SUPPORT | $7,500 |
Over the last fiscal year, we have identified 4 grants that Jackson Laboratory has recieved totaling $210,550.
Awarding Organization | Amount |
---|---|
Inadcure Foundation Inc Fairfield, NJ | | $156,115 |
Hunters Cmt4b3 Research Foundation Inc Scarsdale, NY PURPOSE: EXAMINING SBF1 IN MUTANT MICE FOR RELEVANT PHENOTYPES | $26,435 |
Becton Family Foundation Tr Homosassa, FL PURPOSE: CONTRIBUTION TO GENERAL FUND | $18,000 |
Becton Family Foundation Tr Homosassa, FL PURPOSE: CONTRIBUTION TO THE HELIX FUND | $10,000 |
Beg. Balance | $386,957,560 |
Earnings | $61,288,861 |
Net Contributions | $6,864,818 |
Other Expense | $9,474,485 |
Ending Balance | $445,636,754 |
Organization Name | Assets | Revenue |
---|---|---|
Broad Institute Inc Cambridge, MA | $1,666,576,375 | $586,860,976 |
Jackson Laboratory Bar Harbor, ME | $1,211,767,628 | $527,504,036 |
Whitehead Institute For Biomedical Research Cambridge, MA | $896,132,656 | $97,603,749 |
Dana Farber Mass General Brigham Cancer Care Inc Boston, MA | $42,647,489 | $95,186,368 |
Pan-Massachusetts Challenge Inc Needham, MA | $4,238,156 | $66,009,480 |
Third Sector New England Inc Boston, MA | $110,017,543 | $70,555,519 |